Nah, at one point he said 'that's a GREAT question Chelsea'
:D
Printable View
Nah, at one point he said 'that's a GREAT question Chelsea'
:D
Check their valuations/recommendations from the past. Very amusing reading. They have no concept of the US healthcare system and have cost their clients millions.
Speaking of that Tim Hunters NBR article was great. Hes one of the few that know their stuff.
PEB up a little bit today. Intriguing.
wow the underwriter must have been working in overdrive today!
Suddenly, out of nowhere, the buyers are lining up again and the sellers are diminishing - I have to say seems a bit suspect, then again, if they actually do achieve what they say they will achieve (that is cash flow break even in well under 2 years time), then 38 cents is still ultra cheap.
Yep 38 cents is quite cheap. I think this is a $2+ stock, or possibly $2.50+, when things start to happen.
Be very cautious Ive seen this before when without real reason the share price of a issue rising close to the close out of a funding date in order me thinks to get it across the line ( read underwtiter here ) then once that was out of the way the S P falling back in some cases to below the issue price, very strange , circa BIL from the 80's !!!!
http://mendonjournal.com/medical-new...-steps-closer/
"sensitivity of 95 percent for higher-risk cancers and a negative predictive value greater than 97 percent".
PEB's road to commercialization may have just encountered a landslip?